Abstract
DLBCL is a common aggressive and curable lymphoma. Refractoriness or relapse is the main etiology of morbidity and mortality. The risk factors as IPI, GEP and IHC are costly, not easily obtained or interpreted.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
